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Abstract
The antiproliferative action of the guanine-specific ribonuclease secreted by Bacillus intermedius (binase) was
studied in different chicken and mouse cell lines. The proliferation rate of chicken embryo fibroblasts, either normal
or Rous sarcoma virus-transformed, was significantly reduced by binase treatment. Among mouse fibroblasts,
v-ras-transformed NIH3T3 cells were sensitive to binase, whereas the growth of non-transformed, v-src-transformed
or v-fms-transformed NIH3T3 cells was not affected. A 48 h treatment with binase inhibited the Ca2-dependent K
current of v-ras-transformed NIH3T3 cells but had no effect on this membrane current in non-transformed and in
v-src- or v-fms-transformed NIH3T3 cells. Our results suggest that mammalian cells expressing the ras-oncogene are
a potential target for the antiproliferative action of binase. © 2001 Elsevier Science Ireland Ltd. All rights reserved.
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1. Introduction
A number of ribonucleases, such as binase
(Bacillus intermedius RNase), pancreatic RNase
A, bovine seminal ribonuclease, and RNase from
oocytes of Rana pipiens (onconase) were shown to
possess enzymatic and biological activities which
may be exploited for the development of novel
cytotoxic agents (Youle et al., 1993; Di Donato et
al., 1994; Mikulski et al., 1995; Boque and Wlo-
dawer, 1996; Prior et al., 1996). To assess the
possibilty of a future clinical application of bacte-
rial ribonucleases, the toxicity of these enzymes in
various cell lines is currently under investigation.
Compared to pancreatic RNase A, binase is a
more effective growth inhibitor of Ehrlich ascites
tumor cells and also of the ascitic form of lymp-
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